Back to top
more

Patterson Companies, Inc. (PDCO)

(Real Time Quote from BATS)

$32.73 USD

32.73
44,305

+0.77 (2.41%)

Updated Apr 21, 2021 10:47 AM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (100 out of 254)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Zacks News

Patterson Cos. (PDCO) Up 9.1% Since Last Earnings Report: Can It Continue?

Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain Patterson Companies (PDCO) Stock

Patterson Companies (PDCO) continues to benefit from strength in Animal Health business and robust product portfolio. However, high debt level remains a woe.

Trina Mukherjee headshot

3 Stocks to Capitalize on Promising Dental Supplies Industry

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

Patterson Companies (PDCO) Q3 Earnings Top Estimates, Up Y/Y

Patterson Companies' (PDCO) fiscal third-quarter 2021 results benefit from strong segmental performance.

Patterson Cos. (PDCO) Surpasses Q3 Earnings and Revenue Estimates

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 13.73% and 4.12%, respectively, for the quarter ended January 2021. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Patterson Companies' (PDCO) Q3 Earnings?

Patterson Companies' (PDCO) fiscal third-quarter results are likely to reflect improvement at Dental segment.

Zimmer Biomet (ZBH) to Report Q4 Earnings: What's in Store?

Zimmer Biomet's (ZBH) patient volumes are expected to have increased significantly in the fourth quarter due to pent-up demand.

STERIS (STE) to Report Q3 Earnings: What's in the Cards?

Within Life Sciences, STERIS (STE) might have registered benefits from pharma customers on growing vaccines, along with a recovery in the Healthcare arm in Q3.

Urmimala Biswas headshot

3 MedTech Stocks Likely to Top Estimates This Earnings Season

Strong signs of rebound in base sales volumes make us optimistic about VIVO, XRAY, and PDCO's results.

Higher Testing to Aid Quest Diagnostics' (DGX) Q4 Earnings

Within non-COVID base business, Quest Diagnostics (DGX) is expected to have secured higher returns in Q4 from the acquisitions of MACL, Memorial Hermann Outreach and Blueprint Genetics.

Abbott (ABT) Q4 Earnings Top, Diagnostic Test Sales Solid

Within Diabetes Care, Abbott (ABT) reports strong sales banking on growing demand for sensor-based continuous glucose monitoring system, FreeStyle Libre.

What's in Store for IDEXX Laboratories (IDXX) in Q4 Earnings?

IDEXX's (IDXX) fourth-quarter top line is likely to have benefited from strength in CAG and LPD businesses.

Boston Scientific (BSX) LOTUS Edge Recall to Mar Q4 Earnings

Per Boston Scientific's (BSX) October update, it has started to see strong region-wise recovery.

Align Technology (ALGN) to Post Q4 Earnings: What's in Store?

Align Technology (ALGN) is expected to have gained from continued recovery in Clear Aligner shipment volumes in Q4.

Hologic's (HOLX) CE-Marked Fluent System Launched in Europe

Hologic (HOLX) aims to optimize, simplify and streamline hysteroscopic workflow with the latest European launch of its fluid management system.

Here's Why You Should Retain AmerisourceBergen (ABC) Now

AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.

Can Diagnostics Aid Hologic (HOLX) Q1 Sales Amid Coronavirus?

Strength in Molecular Diagnostics business is likely to have continued to aid Hologic's (HOLX) performance in the first quarter of fiscal 2021 amid the coronavirus-led economic doldrums.

Here's Why You Should Retain AMN Healthcare (AMN) Stock Now

AMN Healthcare (AMN) continues to gain traction from its wide range of services, and Healthcare MSP. Intense competition remains a woe.

What's in Store for Edwards Lifesciences in (EW) Q4 Earnings?

Robust customer adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve is likely to have driven Edwards Lifesciences' (EW) Q4 revenues.

Here's Why You Should Add Hologic (HOLX) to Your Portfolio

Investors continue to be optimistic about Hologic (HOLX) due to a slew of regulatory approvals and buyouts.

Cardiovascular Systems' (CSII) OAS Gets CE Mark for Use in Europe

Cardiovascular Systems (CSII) aims to expand treatment options in Europe for patients suffering from severely calcified coronary artery disease following the receipt of regulatory clearance.

Quest Diagnostics (DGX) COVID-19 Test Sales Solid, Volume Dull

Quest Diagnostics (DGX) notes strong signs of the healthcare system returning to pre-pandemic levels with base testing volume gradually improving.

NEOGEN's (NEOG) New Test to Aid in Detecting Cancer-Causing Toxin

NEOGEN's (NEOG) latest test is expected to simplify the process of milk testing as well as detecting lower levels of the carcinogenic metabolite Aflatoxin M1.

Integra (IART) Preliminary Q4 Reported Sales Show Recovery

Integra's (IART) sales improvement in the fourth quarter is likely to have been boosted by on-going business recovery.

Thermo Fisher (TMO) Rides on End Market Growth Amid Pandemic

Thermo Fisher (TMO) launches Amplitude Solution to automate high-throughput PCR-based testing and significantly expands capacity for viral transport media production in Europe.